Swiss National Bank Concert Pharmaceuticals, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$9.44 - $13.12 $293,508 - $407,927	-31,092 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.25 - $16.17 $51,750 - $74,382	4,600 Added 17.36%	31,092 $390,000
Q1 2018 May 04, 2018	SELL	$19.24 - $28.03 $25,011 - $36,439	-1,300 Reduced 4.68%	26,492 $607,000
Q3 2017 Nov 03, 2017	BUY	$13.91 - $15.31 $386,586 - $425,495	27,792	27,792 $410,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.